Insider Transactions in Q4 2022 at Nu Skin Enterprises, Inc. (NUS)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.48%
|
$40,000
$40.75 P/Share
|
|
Dec 20
2022
|
Chayce David Clark EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
61,836
+42.23%
|
-
|
|
Dec 18
2022
|
Joseph Y Chang Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,542
-21.98%
|
$261,680
$40.33 P/Share
|
|
Dec 18
2022
|
Joseph Y Chang Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,800
+18.6%
|
$251,600
$37.58 P/Share
|
|
Dec 12
2022
|
Emma S. Battle Director |
BUY
Small Acquisition
|
Direct |
18
+0.23%
|
$738
$41.63 P/Share
|
|
Dec 07
2022
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.08%
|
$560
$40.98 P/Share
|
|
Nov 25
2022
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-16.93%
|
$950,000
$38.45 P/Share
|
|
Nov 25
2022
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+8.14%
|
$850,000
$34.11 P/Share
|
|
Nov 22
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.46%
|
$38,000
$38.16 P/Share
|
|
Oct 21
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.44%
|
$35,000
$35.92 P/Share
|